Fig. 2.
PCAF enhances MMP-9 promoter activity and its HAT activity is necessary for optimal induction. (A) Schematic diagram of PCAF and deletion constructs. HAT: histone acetyltransferase activity domain; Bromo: bromodomain. (B) HeLa cells were transiently transfected with the MMP-9-Luc reporter construct and 0 to 0.6 µg of pCX-PCAF, pCX-PCAF ΔHAT1 or pCX-PCAF ΔHAT2, and MMP-9 promoter activity determined as described in Materials and Methods. The results are the mean ± S.E. of at least three independent experiments. * p ≤0.05 compared to pcDNA3 only transfected PMA treated samples; # p ≤0.05 between the two linked samples; NS, not significant compared to pcDNA3 only transfected PMA treated samples. (C) HeLa cells were transiently transfected with 0.4 µg of pcDNA3, pCX-FLAG-PCAF, pCX-FLAG-PCAF ΔHAT1 or pCX-FLAG-PCAF ΔHAT2 for 48 h, and whole cell lysates isolated and subjected to immunoblotting analysis. Actin was utilized as a loading control.
